Sprint Bioscience AB (publ) (STO:SPRINT)

Sprint Bioscience AB Revenue

Sprint Bioscience AB had revenue of 5.00K SEK in the quarter ending June 30, 2026, a decrease of -99.96%. This brings the company's revenue in the last twelve months to 139.21M, up 106.43% year-over-year. In the year 2025, Sprint Bioscience AB had annual revenue of 167.65M with 148.60% growth.

• Revenue (ttm): 139.21M
• Revenue Growth: +106.43%
• P/S Ratio: 2.51
• Revenue / Employee: 4.63M
• Employees: 30
• Market Cap: 348.20M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	167.65M	100.21M	148.60%
Dec 31, 2024	67.44M	13.12M	24.16%
Dec 31, 2023	54.32M	53.87M	12,051.01%
Dec 31, 2022	447.00K	-34.63M	-98.73%
Dec 31, 2021	35.07M	15.47M	78.88%
Dec 31, 2020	19.61M	-14.54M	-42.58%
Dec 31, 2019	34.15M	15.95M	87.66%
Dec 31, 2018	18.20M	-15.23M	-45.57%
Dec 31, 2017	33.43M	-13.59M	-28.91%
Dec 31, 2016	47.02M	33.57M	249.54%
Dec 31, 2015	13.45M	8.84M	191.58%
Dec 31, 2014	4.61M	-2.92M	-38.78%
Dec 31, 2013	7.54M	3.53M	87.92%
Dec 31, 2012	4.01M	1.63M	68.59%
Dec 31, 2011	2.38M	-	-

Data Source: Fiscal.ai Last updated: Aug 27, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error